cas 2222755-14-6

LOXO-292 (CAS No.: 2222755-14-6) is a potent, oral, highly selective rearrangement during transfection (RET) kinase inhibitor for the treatment of cancer patients with abnormal RET. Our company produces 50KG/M of LOXO-292 (CAS No.: 2222755-14-6) every month, adequate inventory. Our company sells more than 50KG/M of LOXO-292 (CAS No.: 2222755-14-6) every year, mainly to the European and American markets and Southeast Asian markets, and has a good foundation for cooperation with many large multinational enterprises.